Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Prospective Monocentric Study on Prostate Cancer Restaging by Using PET/MR With Innovative Radiotracers

NCT05806853 is registered in ClinicalTrials.gov with IRCCS San Raffaele as lead sponsor.

NCT NCT05806853
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05806853 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Prospective Monocentric Study on Prostate Cancer Restaging by Using PET/MR With Innovative Radiotracers
Lead sponsor
IRCCS San Raffaele
Phase
Phase 2
Overall status
Completed
Start date
June 3, 2020
Completion date
October 5, 2022
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer